PiB-, florbetapir-PET yield same results for Alzheimer's diagnosis

01/9/2013 | HealthImaging.com

PET imaging of beta-amyloid levels using Pittsburgh compound B or florbetapir yielded consistent results, according to a study in the Journal of Nuclear Medicine. The two methods gave concordant beta-amyloid positive and negative status and comparable cortical retention ratios, the study found. "These analyses are an initial step in addressing the need for standardization of AB methodologies," researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA